ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPRO CORPORATION
  3. Financials
  4. Revenue growth (%)

NIPRO CORPORATION (8086)

Market cap
¥278.9B
P/E ratio
20.5x
Nipro manufactures medical devices, generic pharmaceuticals, and pharma packaging materials, serving healthcare institutions with products like dialysis equipment, syringes, and glass vials.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 20259.9+29.10%
Mar 31, 20247.6-25.12%
Mar 31, 202310.2+18.35%
Mar 31, 20228.6+191.86%
Mar 31, 20213-21.96%
Mar 31, 20203.8-51.79%
Mar 31, 20197.8-20.97%
Mar 31, 20189.9-622.11%
Mar 31, 2017-1.9-114.86%
Mar 31, 201612.8+58.10%
Mar 31, 20158.1-67.35%
Mar 31, 201424.8+81.14%
Mar 31, 201313.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat